Myriad Genetics, Inc. (MYGN) Stock

Myriad Genetics, Inc. (MYGN) is a Healthcare stock trading at $4.54 (as of 2026-06-18), with a market capitalization of $374.96M and a trailing P/E of -0.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Myriad Genetics, Inc. develops and commercializes genetic tests used in clinical decision-making, including molecular diagnostic assays for oncology and women’s and mental health. Its offerings include germline and tumor companion diagnostics and prognostic tests such as MyRisk, BRACAnalysis CDx, MyChoice CDx, Prolaris, and EndoPredict, which it sells in the United States and internationally.

Valuation — source: SEC EDGAR (first-party)
Price$4.54
Market Cap$374.96M
P/E Ratio-0.9
EV / EBITDA-1.3
Price / Book1.11
Price / Sales0.45
DCF Value (model)$0.82
DCF Upside vs Price-81.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$824.50M
Net Margin-44.4%
Return on Equity-118.5%
Debt / Equity0.53
Current Ratio2.40
Revenue Growth (YoY)-1.6%
EPS Growth (YoY)180.1%
Financial Health — source: SEC EDGAR
Altman Z-Score-1.78 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-0.9
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-104.4%
vs Industry-105.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderORBIMED ADVISORS LLC ($122.88M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOSamraat S. Raha
Employees2,700
CountryUS
IPO Date1995-10-06

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Castle Biosciences, Inc. (CSTL)
  • CareDx, Inc (CDNA)
  • Fulgent Genetics, Inc. (FLGT)
  • Personalis, Inc. (PSNL)
  • Absci Corporation (ABSI)
  • National Research Corporation (NRC)
  • OmniAb, Inc. (OABI)
  • Achieve Life Sciences, Inc. (ACHV)
MYGN earnings history · MYGN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.